Sefaxersen sodium
Sefaxersen sodium is a specific antisense oligonucleotide (ASO) targeting complement factor B (CFB) . Sefaxersen sodium effectively reduces circulating levels of CFB, and can be used for geographic atrophy (GA) research[1][2].
Product Specifications
CAS Number
2272983-11-4
Product Name Alternative
IONIS-FB-LRx sodium; RG6299 sodium; ISIS 696844 sodium
UNSPSC
12352208
Target
Complement System
Type
Oligonucleotides
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/ionis-fb-lrx-sodium.html
Purity
93.90
Solubility
H2O : 100 mg/mL (ultrasonic)
Smiles
[Sefaxersensodium]
Molecular Weight
8678.96 (free acid)
References & Citations
[1]Dreismann AK, et al. Gene targeting as a therapeutic avenue in diseases mediated by the complement alternative pathway. Immunol Rev. 2022 Nov 12.|[2]Mahmoudzadeh R, et al. Emerging treatments for geographic atrophy in age-related macular degeneration. Curr Opin Ophthalmol. 2021 May 1;32 (3) :294-300.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Oligonucleotides
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
